PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹892 Cr | ₹1,005 Cr | ₹484 Cr | ₹766 Cr | ₹598 Cr |
What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹892 Cr |
| Mar2024 | ₹1,005 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹766 Cr |
| Mar2021 | ₹598 Cr |
How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹892 Cr | -11.17 | |
| Mar2024 | ₹1,005 Cr | 107.60 | |
| Mar2023 | ₹484 Cr | -36.86 | |
| Mar2022 | ₹766 Cr | 28.25 | |
| Mar2021 | ₹598 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,410.3 Cr | -1.4% | -13.8% | -31.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,753.0 Cr | -0.2% | 1.1% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,205.0 Cr | 0.7% | -2.9% | 6.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,169.0 Cr | -0.9% | -1.6% | 13.6% | Stock Analytics | |
| CIPLA | ₹121,166.0 Cr | 0.7% | -2.4% | 4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,749.0 Cr | 2.2% | 2.8% | 2.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -1.4% |
-13.8% |
-31.9% |
| SENSEX | 0% |
0.1% |
3.9% |
You may also like the below Video Courses